| Literature DB >> 29858679 |
Hsiao-Wen Huang1, Yen-Hung Lin2, Min-Hsuan Lin3, Ya-Rong Huang4, Chih-Hung Chou4, Hsiao-Chin Hong4, Mei-Ren Wang5, Yu-Ting Tseng5, Po-Chun Liao5, Min-Chuan Chung5, Yu-Jie Ma5, Shou-Cheng Wu6, Yung-Jen Chuang7, Horng-Dar Wang8, Yun-Ming Wang9, Hsien-Da Huang10, Tsai-Te Lu11,12, Wen-Feng Liaw13.
Abstract
The ubiquitous and emerging physiology function of endogenous nitric oxide in vascular, myocardial, immune, and neuronal systems prompts chemists to develop a prodrug for the controlled delivery of ·NO in vivo and for the translational biomedical application. Inspired by the discovery of natural [Fe(NO)2] motif, herein, we develop the synthetic dinitrosyl iron complexes (DNICs) [Fe2(μ-SR)2(NO)4] (1) as a universal platform for the O2-triggered release of ·NO, for the regulation of ·NO-release kinetics (half-life = 0.6-27.4 h), and for the activation of physiological function of ·NO. Using C. elegans as a model organism, the ·NO-delivery DNIC 1 regulates IIS signaling pathway, AMPK signaling pathway, and mitochondrial function pathway to extend the lifespan and to delay the aging process based on the lifespan analysis, SA-βgal activity assay, and next-generation RNA sequencing analysis. This study unveils the anti-aging effect of ·NO and develops DNICs as a chemical biology probe for the continued discovery of unprecedented NO physiology.Entities:
Keywords: Aging; Bioinorganic chemistry; Biomedicine; Drug delivery; Nitric oxide
Mesh:
Substances:
Year: 2018 PMID: 29858679 DOI: 10.1007/s00775-018-1569-1
Source DB: PubMed Journal: J Biol Inorg Chem ISSN: 0949-8257 Impact factor: 3.358